Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Goodwill & Intangibles (2023 - 2026)

bioAffinity Technologies has reported Goodwill & Intangibles over the past 4 years, most recently at $2.1 million for Q1 2026.

  • Quarterly Goodwill & Intangibles fell 2.69% to $2.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.1 million through Mar 2026, down 2.69% year-over-year, with the annual reading at $2.1 million for FY2025, 2.68% down from the prior year.
  • Goodwill & Intangibles was $2.1 million for Q1 2026 at bioAffinity Technologies, down from $2.1 million in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $3.6 million in Q1 2024 and troughed at $2.1 million in Q1 2026.
  • The 4-year median for Goodwill & Intangibles is $2.2 million (2024), against an average of $2.4 million.
  • Year-over-year, Goodwill & Intangibles dropped 2.61% in 2024 and then plummeted 40.32% in 2025.
  • A 4-year view of Goodwill & Intangibles shows it stood at $2.2 million in 2023, then fell by 2.61% to $2.2 million in 2024, then fell by 2.68% to $2.1 million in 2025, then decreased by 0.69% to $2.1 million in 2026.
  • Per Business Quant, the three most recent readings for BIAF's Goodwill & Intangibles are $2.1 million (Q1 2026), $2.1 million (Q4 2025), and $2.1 million (Q3 2025).